Medicure (MPH.V) traded up 4.76 % during a 24 hours period ending at 09:02 AM Central Europe on Tuesday 27th. One Medicure stock can currently be bought for about CAD 4.4 on popular exchanges. Current supply of Medicure stocks is 10.4 mn. Medicure has a current market capitalization of CAD 43.8 mn and approximately CAD 56.3 k worth of Medicure was traded on exchanges in the last 24 hours. Since last month end, Medicure has traded 61.76 % up. Simple moving average of last 200 days is at CAD 1.54. The highest price of past 52 weeks was recorded at CAD 4.95 on 10/13/2026. 52 weeks low was at CAD 0.85 on 04/24/2026.
Here is how related stocks have performed in the past 24 hours:
Tdb Split (XTD.TO) traded up 0.11 % and now trades at CAD 9.49. Current market capitalisation for Tdb Split is CAD 51.8 mn. Current price/earnings ratio for Tdb Split is 1.37.
Arch Bio (ARCH.V) traded down -1.15 % and now trades at CAD 0.86. Current market capitalisation for Arch Bio is CAD 52.2 mn.
Source Rock Royalties (SRR.V) traded up 1.77 % and now trades at CAD 1.15. Current market capitalisation for Source Rock Royalties is CAD 51.5 mn. Current price/earnings ratio for Source Rock Royalties is 25.7.
Bp Silver (BPAG.V) traded down -1.28 % and now trades at CAD 0.77. Bp Silver has a market capitalisation of CAD 52.3 mn.
Nurexone Biologic (NRX.V) traded down -7.41 % and now trades at CAD 0.5. Current market capitalisation for Nurexone Biologic is CAD 52.1 mn.
About Medicure
Medicure Inc. is a cardiovascular drug discovery and development company based in Princeton, Canada. The company is concentrated on developing therapeutics to meet the unfulfilled needs in the field of cardiovascular medicine. Their current focus is on preventing and treating ischemia, ischemic reperfusion injury, and stroke. You can find more information about the company and its offerings on their website, www.medicure.com , and they are listed on the TSX Venture Exchange. Their Initial Public Offering (IPO) date back to March 29, 1999.